A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|10|17|1759-1764

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.10, Iss.17, 2003-09, pp. : 1759-1764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive &bgr;-Cell Dysfunction and Metabolic Syndrome

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 495-501

Bentham Science Publishers

Access to resources Recommend Favorite

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

By Cai H.   Griendling K.K.   Harrison D.G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 9, 2003-09 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite

Atorvastatin and Diabetic Vascular Complications

By  

Current Pharmaceutical Design, Vol. 12, Iss. 12, 2006-04 ,pp. : 1549-1554

Bentham Science Publishers

Access to resources Recommend Favorite

The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase

By Laplante Marc-André   de Champlain Jacques  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 1, 2006-01 ,pp. : 21-28

NRC Research Press

Access to resources Recommend Favorite

Is Vascular Stiffness a Target for Therapy?

By Duprez Daniel  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 305-310

Springer Publishing Company

Access to resources Recommend Favorite